A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Ivana Gojo, Jan H. Beumer, Keith W. Pratz, Michael A. McDevitt, Maria R. Baer, Amanda L. Blackford, B. Douglas Smith, Steven D. Gore, Hetty E. Carraway, Margaret M. Showel, Mark J. Levis, Amy E. Dezern, Douglas E. Gladstone, Jiuping Jay Ji, Lihua Wang, Robert J. Kinders, Marie Pouquet, Ismail Ali-Walbi, Michelle A. Rudek, Weijie PohJames G. Herman, Larry M. Karnitz, Scott H. Kaufmann, Alice Chen, Judith E. Karp

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences